The study did not meet its primary endpoint of a 0.3 logMAR difference between treated and untreated eyes at week 48 , but it did demonstrate bilateral improvement of visual acuity from nadir to week 96.
Erin Boyle
Erin Boyle is a medical writer and editor with more than 15 years’ experience writing and reporting on a variety of topics, including oncology, immunology, neurology. For more than a decade of that time, she’s specialized in ophthalmology, first as a staff writer and managing editor (of the European and Asia-Pacific editions) at Ocular Surgery News, then as a senior staff writer and editor at EyeWorld, the official publication of the American Society of Cataract and Refractive Surgery. She’s traveled to ophthalmology conferences around the world, writing daily news and follow-up pieces for ophthalmologists and savvy patients.
